KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xylem (XYL) Equity Average (2016 - 2025)

Historic Equity Average for Xylem (XYL) over the last 15 years, with Q3 2025 value amounting to $11.2 billion.

  • Xylem's Equity Average rose 645.41% to $11.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 billion, marking a year-over-year increase of 645.41%. This contributed to the annual value of $10.4 billion for FY2024, which is 5222.6% up from last year.
  • Xylem's Equity Average amounted to $11.2 billion in Q3 2025, which was up 645.41% from $11.0 billion recorded in Q2 2025.
  • In the past 5 years, Xylem's Equity Average ranged from a high of $11.2 billion in Q3 2025 and a low of $3.0 billion during Q1 2021
  • Its 5-year average for Equity Average is $6.8 billion, with a median of $6.7 billion in 2023.
  • Its Equity Average has fluctuated over the past 5 years, first surged by 231.51% in 2021, then skyrocketed by 20896.5% in 2023.
  • Quarter analysis of 5 years shows Xylem's Equity Average stood at $3.2 billion in 2021, then increased by 6.27% to $3.4 billion in 2022, then skyrocketed by 199.14% to $10.1 billion in 2023, then grew by 5.62% to $10.6 billion in 2024, then increased by 4.96% to $11.2 billion in 2025.
  • Its last three reported values are $11.2 billion in Q3 2025, $11.0 billion for Q2 2025, and $10.7 billion during Q1 2025.